ChemOn

ChemOn Inc. is the first privately established CRO in the non-clinical field in Korea, certified under GLP (Good Laboratory Practice), and equipped with appropriate facilities and researchers. Standard operating procedures for each study, as well as the operation of facilities and equipment, are strictly followed to conduct various tests required for the development of new drugs, health supplements, cosmetics, and more. Due to multilateral agreements such as free trade agreements, especially between Korea and the United States, all domestic industries have entered an era of unlimited competition. The development of new materials is particularly crucial for the biotechnology industry, serving as a next-generation growth engine for Korea. Toxicity and efficacy testing are also of utmost importance. As ChemOn Inc., we have served on advisory boards alongside prominent figures from various academic fields since our establishment in 2000. We continuously learn from them to execute and provide GLP testing that can be recognized anywhere in the world, fulfilling such market demands. Consequently, non-clinical data from recent studies on new drugs has been submitted as certification data both overseas and domestically for NDA filings, enabling seamless clinical approval and licensing of new drugs.